Cigna joined the parade of health insurance companies and biotech giants backing GNS Healthcare, a technology firm applying machine learning to healthcare through precision medicine.
GNS said Tuesday it has raised $23 million led by Cigna Ventures as the health insurer looks to more precisely "match therapeutics, procedures and care management interventions to individuals to drive personalized clinical care," GNS and Cigna said in a statement.
The Cigna investment fits the effort by health insurance companies to use claims data and related patient health information to better target illness and provide more cost-effective and high-quality patient care.
These efforts are also consistent with health insurer efforts to move away from fee-for-service medicine to value-based models that manage populations of patients, making sure healthcare is delivered in the right place, at the right time and in the right amount.
Join the Conversation